Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
AVD · NYSE · United States · Agricultural Chemicals
In shortAMERICAN VANGUARD CORP is loss-making, burns cash and carries moderate debt, with revenue shrinking (−5.9% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -5.5% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -9.7% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -23.4% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -6.1% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.77× | 81/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.90× | 61/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -1.53× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.80 | 44/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -4.9% | 1/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 2 of 5 | 25/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 12.2% | 66/100 |
| Operating margin volatility | 10.7% | 12/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -5.5% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 558 | 610 | 579 | 547 | 515 |
| Cost of revenue | 387 | 417 | 400 | 427 | 368 |
| Gross profit | 171 | 192 | 179 | 120 | 148 |
| Research & development | 29 | 32 | 38 | 33 | 23 |
| Selling, general & admin | 111 | 120 | 117 | 120 | 111 |
| Operating income | 31 | 41 | 23 | (102) | (28) |
| Interest expense | 3.7 | 4 | 13 | 17 | 18 |
| Pre-tax income | 27 | 36 | 10 | (120) | (47) |
| Income tax | 8.2 | 8.6 | 2.8 | 5.9 | 2.7 |
| Net income | 19 | 27 | 7.5 | (126) | (50) |
| Diluted EPS | $0.61 | $0.92 | $0.26 | −$4.50 | −$1.75 |
| Diluted shares (millions) | 30 | 30 | 29 | 28 | 28 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
2.80 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Sep 30, 2026